Greg Keenan, Chief Medical Officer at Aurinia Pharmaceuticals Inc. (AUPH), sold 16,610 shares at $8.23 ($137K) on 2025-03-07, disclosed to the SEC on 2025-03-07.
Open-market sale of $137k AUPH by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.23 | 8,305 | $68K | 50.0% |
| 2 | $8.23 | 8,305 | $68K | 50.0% |
| Total | $8.23 avg | 16,610 | $137K | 100% |
| Filing → |